BNP Is Better Than ANP for Monitoring Heart Failure Severity in Outpatients
BNP correlated most strongly with NYHA heart failure class in outpatients, outperforming C-ANP and N-ANP, supporting BNP as the preferred biomarker for monitoring treatment response.
Quick Facts
What This Study Found
BNP correlated most strongly with NYHA heart failure classification and treatment response in outpatients, outperforming C-terminal ANP and N-terminal ANP as a monitoring biomarker.
Key Numbers
How They Did This
Cross-sectional study comparing C-ANP, N-ANP, and BNP levels against NYHA class in outpatient heart failure patients. Biomarker performance assessed for treatment monitoring utility.
Why This Research Matters
Monitoring heart failure treatment effectiveness requires reliable biomarkers. This study confirms BNP's superiority for outpatient monitoring, guiding clinical practice and laboratory test selection.
The Bigger Picture
Biomarker-guided heart failure management — adjusting treatment based on BNP trends rather than just symptoms — has the potential to improve outcomes by enabling more precise therapy adjustment.
What This Study Doesn't Tell Us
Cross-sectional design; serial monitoring over time would provide stronger evidence. Specific NYHA-BNP correlation coefficients not detailed. Treatment heterogeneity in outpatient population.
Questions This Raises
- ?Should BNP targets guide heart failure drug dosing?
- ?Does serial BNP monitoring reduce heart failure hospitalizations?
- ?Can BNP distinguish between stable and deteriorating outpatient heart failure?
Trust & Context
- Key Stat:
- BNP wins BNP correlated most strongly with functional heart failure class in outpatients, confirming it as the preferred monitoring biomarker over ANP variants
- Evidence Grade:
- Moderate evidence from a comparative biomarker study with clinical severity correlation in outpatient heart failure.
- Study Age:
- Published in 2002. BNP/NT-proBNP-guided heart failure management is now recommended in clinical guidelines.
- Original Title:
- The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
- Published In:
- Journal of cardiac failure, 8(3), 149-54 (2002)
- Authors:
- Lee, Shang-Chiun, Stevens, Tracy L, Sandberg, Sharon M, Heublein, Denise M, Nelson, Susan M, Jougasaki, Michihisa, Redfield, Margaret M, Burnett, John C
- Database ID:
- RPEP-00744
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Which blood test is best for monitoring heart failure?
BNP. This study confirms it tracks heart failure severity better than ANP variants in outpatients. Doctors can use BNP trends to assess whether treatment is working.
Should heart failure patients get regular BNP tests?
Clinical guidelines now recommend serial BNP/NT-proBNP monitoring to guide treatment. Studies like this one built the evidence supporting that recommendation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00744APA
Lee, Shang-Chiun; Stevens, Tracy L; Sandberg, Sharon M; Heublein, Denise M; Nelson, Susan M; Jougasaki, Michihisa; Redfield, Margaret M; Burnett, John C. (2002). The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.. Journal of cardiac failure, 8(3), 149-54.
MLA
Lee, Shang-Chiun, et al. "The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.." Journal of cardiac failure, 2002.
RethinkPeptides
RethinkPeptides Research Database. "The potential of brain natriuretic peptide as a biomarker fo..." RPEP-00744. Retrieved from https://rethinkpeptides.com/research/lee-2002-the-potential-of-brain
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.